Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5651–5700 of 18644
On April 23, 2024, the Board approved the appointment of the Company’s current Chief Accounting Officer, Controller and Principal Accounting Officer, Randall Pollard, as Principal Financial Officer of the Company, to be effective upon the Effective Date.
On April 19 2024, 374Water Inc. (the “ Company ”) entered into an employment agreement with Christian Gannon (the “ Employment Agreement ”), for Mr. Gannon to serve as President and Chief Executive Officer of the Company effective April 22, 2024 (the “ Start Date ”).
On April 19, 2024, NeoVolta, Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Ardes Johnson pursuant to which Mr. Johnson agreed to serve as the Company’s chief executive officer commencing April 29, 2024.
appointed Daniel R. Hopgood, 52, as Executive Vice President, Chief Financial Officer of the Company, effective on his first day of employment, anticipated to be May 20, 2024
Ms. Warner succeeds Christopher Conley, who is assuming the position of Senior Vice President and Chief Financial Officer for Whirlpool North America, effective May 1, 2024.
designating Kevin D. Chapman to become Chief Executive Officer of the Company and the Bank, effective May 2025.
extends the expiration date of the Hagerty employment agreement from April 30, 2024 to April 30, 2025 (the “Extended Term”), at which time Mr. Hagerty intends to retire from the Company;
James Barr, IV, the Chief Executive Officer of the Company, and Becky L. Alseth, the Chief Marketing Officer of the Company, separated their service with the Company, effective immediately following the Closing
Aina E. Konold, the Chief Financial Officer of the Company, and John R. Goelz, the Chief Operating Officer of the Company, will separate service with the Company, effective as of May 3, 2024.
the Board of Directors has appointed Sheri L. Dodd as the Company’s Chief Executive Officer, effective July 1, 2024
Daniel L. Reuvers has informed the Company’s Board of Directors of his decision to retire as Chief Executive Officer, effective as of June 30, 2024
On April 22, 2024, the Board of Directors of Beacon Roofing Supply, Inc. (the “Company”) appointed Prithvi (Prith) Gandhi, age 54, as the Company’s Executive Vice President and Chief Financial Officer.
Jun (Joe) Yan, the Company's Chief Executive Officer, Vivian Liu, the Company's Chief Operating Officer and Chief Financial Officer, and Mauricio Monico, the Company's Chief Product Officer, ceased to serve in their respective positions and as employees of the Company
Jun (Joe) Yan, the Company's Chief Executive Officer, Vivian Liu, the Company's Chief Operating Officer and Chief Financial Officer, and Mauricio Monico, the Company's Chief Product Officer, ceased to serve in their respective positions and as employees of the Company
Brett Just was appointed to serve as the Company' Chief Financial Officer
Rishi Bajaj, one of the Company's directors, remained on the Board and became the Company's Chief Executive Officer
● Shanoop Kothari, our Co-Chief Executive Officer and acting Chief Financial Officer, was named sole Chief Executive Officer, as part of our previously announced management transition plan;
● As part of such previously announced management transition plan, Brian Ferdinand, our founder, stepped down as our Chairman of the Board and Co-Chief Executive Officer and became a consultant to our company, in which role he will oversee the management and expansion of our hotel properties portfolio and assist Mr. Kothari in his transition to sole Chief Executive Officer;
In connection with the Transaction, as of April 16, 2024, Daniel J. Heinlein, President and Chief Executive Officer of JRG Re, joined Buyer, and is no longer employed by a subsidiary of the Company.
On April 20, 2024, Scott W. Wine resigned as Chief Executive Officer and Executive Director of CNH Industrial N.V.
Upon Mr. Wine’s resignation, the Board of the Company has appointed Mr. Gerrit Marx as the Company’s Chief Executive Officer effective as of July 1, 2024.
On and effective as of April 21, 2024, prior to the commencement of the Chapter 11 Cases, the Company appointed Mr. Still as Senior Vice President and Chief Financial Officer.
On April 19, 2024, Archer-Daniels-Midland Company (the “Company”) and Vikram Luthar entered into a Transition Agreement (the “Agreement”) under which Mr. Luthar will resign effective September 30, 2024
On April 22, 2024, Lindblad Expeditions Holdings, Inc. (the “Company”) announced the departure of Craig Felenstein, Chief Financial Officer for the Company, effective May 31, 2024, who is pursuing a non-competitive opportunity.
appointed Ms. Lynn M. Hopkins, Interim Executive Vice President and Chief Financial Officer of the Company and the Bank, as the Company’s and the Bank’s permanent Executive Vice President and Chief Financial Officer.
and Michael Friedman, the Company’s President and CFO, was appointed as CEO of the Company.
On April 18, 2024, Innovative MedTech, Inc. (the “Company”) terminated Merle Griff, PhD., as the Company’s CEO
(i) Thomas D. Hennessy - Chairman and Chief Executive Officer of the Company
(ii) Nicholas Geeza - Chief Financial Officer of the Company
led by Garry Lowenthal, the Company’s new Chief Financial Officer.
Effective April 16, 2024, the Board appointed Jeffrey Peck to serve as Chief Executive Officer and Interim Chief Financial Officer.
Effective April 16, 2024, Robert J. Zulkoski relinquished his role as Chief Executive Officer of the Company.
Effective April 16, 2024, the Board appointed Jeffrey Peck to serve as Chief Executive Officer and Interim Chief Financial Officer.
Effective April 17, 2024, Mr. Peck resigned as Interim Chief Financial Officer.
Effective April 17, 2024, the Board appointed Rob Vanderbeek to serve as Interim Chief Financial Officer pursuant to a Letter of Engagement between Novo Advisors, LLC and the Company, dated April 16, 2024.
On April 18, 2024, Blake Lawson delivered a letter of resignation to RumbleOn, Inc. (the "Company") under Section 5(b) of the Executive Employment Agreement dated as of January 19, 2023, by and between Mr. Lawson and the Company. Mr. Lawson will continue to serve as Chief Financial Officer of the Company through the Company's 2024 Annual Meeting of Shareholders on June 4, 2024.
On April 22, 2024, Clover Health Investments, Corp. (the “Company”) announced that Peter Kuipers will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024, as approved by the Board of Directors of the Company on April 16, 2024.
Mr. Kuipers will succeed Terrence Ronan, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Kuipers becomes Chief Financial Officer, and thereafter cease to serve as the Company’s principal financial officer and principal accounting officer.
On April 20, 2024, the Company and Hull Xu entered into an Offer Letter (the “Offer Letter”), dated as of April 19, 2024, providing for the employment of Mr. Xu as the Company’s Chief Financial Officer and principal financial officer.
On April 17, 2024, Bernard Chung, Acting Chief Financial Officer of the Company, notified the Company of his intention to resign effective April 29, 2024.
On April 15, 2024, Mr. Jim McCarthy resigned from his position as the Company’s Chief Financial Officer, effective as of such date.
On April 15, 2024, Wilhelmina International, Inc. (the “ Company ”) engaged Mr. Gaurav Pahwa as the Company’s Chief Financial Officer
Mr. Lane, Senior Vice President and Interim Chief Financial Officer, and Richard S. Smith, Jr., Senior Vice President, General Counsel, and Secretary, were notified that their employment with the Company will be terminated with an effective date of no later than May 31, 2024, in the case of Mr. Smith, and no later than June 30, 2024, in the case of Mr. Lane, in each case unless an earlier termination date is mutually agreed between each executive officer and the Company.
received a notice from Tham Choi Kuen (“Ms. Kuen”), who served as the Chief Financial Officer (the “CFO”) of the Company, of her decision to resign as the CFO of the Company due to health reasons effective immediately.
the Board determined that upon Ms. Kuen’ resignation on April 18, 2024, Aiden Lee Ping Wei (“Mr. Aiden Lee”), the Company’s current Chief Executive Officer and director, will serve as the Company’s interim CFO and will assume the roles of principal financial officer and principal accounting officer.
On April 15, 2024, in conjunction with Mr. Tsai’s resignation as the Company’s Chief Executive Officer, the Company appointed Hai Shi and Xuedong (Tony) Tian to serve as the Company’s new Co-Chief Executive Officers, effective April 15, 2024.
On April 15, 2024, Jim S. Tsai notified Hai Shi, the Chairman of the Board of Directors (the “Board”) and Chief Strategy Officer of Snail, Inc. (the “Snail”), of his decision to resign from his position as the Chief Executive Officer of Snail
On April 15, 2024, in conjunction with Mr. Tsai’s resignation as the Company’s Chief Executive Officer, the Company appointed Hai Shi and Xuedong (Tony) Tian to serve as the Company’s new Co-Chief Executive Officers, effective April 15, 2024.
On April 15, 2024, Juan Fernandez Pascual tendered to the board of directors of Aimei Health Technology Co., Ltd. (the “ Company ”) his resignation, effective as of that date, as Chief Executive Officer, Secretary and a director of the Company.
On April 19, 2024, the board of directors of the Company appointed Mr. Junheng Xie as the Chief Executive Officer, Secretary and a director of the Company with effect from April 15, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.